Increasing evidence revealed that FXR acts as a tumor promoter by activating carcinogenesis processes such as EMT, metastasis, and drug resistance [9], aligning with our observations in TGF-β1-induced cell and mouse metastatic models. This evidence concerns the gene NR1H4 and neoplasm.